http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100898358-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-26 |
| filingDate | 2002-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100898358-B1 |
| titleOfInvention | New heterocyclic compounds and their pharmaceutical uses |
| abstract | The novel heterocyclic compound according to the present invention is a novel heterocyclic compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof:n n n n n n n n In the above formula,n n n R 1 represents H or C 1-6 alkyl,n n n R 2 is H, -CO-C (R 4 ) = C (R 4 ) -R 5 , wherein R 4 represents H or C 1-4 alkyl, R 5 is C 4-8 alkyl, C 2 -8 alkenyl and the like);n n n In the above formula, X represents O and S, R 7 represents the same meaning as R 4, and R 8 represents R 10 -C (R 9 ) = C (R 9 )-(wherein R 9 represents the same meaning as R 4 , R 10 represents C 3-6 alkyl and the like), R 14 represents the same meaning as R 4, and R 15 represents aryl and the like.n n n Y- (CH 2 ) n -O- binds to position 6 or 7 of the tetrahydroisoquinoline skeleton, and n represents an integer of 1-4.n n n In addition, the compound (I) of the present invention is an antihyperglycemic agent, an antihyperlipidemic agent, an insulin resistance improving agent, an antidiabetic agent, an antidiabetic agent, an impaired glucose tolerance improving agent, an anti-arteriosclerosis agent, an anti-obesity agent, an anti-inflammatory agent, a preventive agent for PPAR mediated diseases. It is useful as a therapeutic agent and an agent for preventing and treating X syndrome. |
| priorityDate | 2001-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 316.